Search for a Medicine

  • Medicines
 
 

Showing 201-220 of 528 matching medicines

Product listings were last updated on 11/07/2020
Trade Name Licence Number & Holder Documents
RENOCIS 1 mg kit for radiopharmaceutical preparation
1 mg
Kit for radiopharmaceutical preparation


Compare
PA0677/005/001
Authorised: 19/03/1999
CIS bio International
SPC PIL
Renvela
0.8 gram(s) Powder for oral suspension

Compare
EU/1/09/521/008
Authorised: 20/09/2018
Genzyme Europe B.V.
SPC PIL IPAR
Renvela
800 milligram(s) Tablet

Compare
EU/1/09/521/1-3
Authorised: 10/06/2009
Genzyme Europe B.V.
SPC PIL IPAR
Renvela
1.6 gram(s) Powder for oral suspension

Compare
EU/1/09/521/4-5
Authorised: 10/06/2009
Genzyme Europe B.V.
SPC PIL IPAR
Renvela
2.4 gram(s) Powder for oral suspension

Compare
EU/1/09/521/6-7
Authorised: 10/06/2009
Genzyme Europe B.V.
SPC PIL IPAR
Repaglinide Accord
0.5 milligram(s) Tablet

Compare
EU/1/11/743/001-005

Accord Healthcare S.L.U.
SPC PIL IPAR
Repaglinide Accord
1 milligram(s) Tablet

Compare
EU/1/11/743/006-010
Authorised: 22/12/2011
Accord Healthcare S.L.U.
SPC PIL IPAR
Repaglinide Accord
2 milligram(s) Tablet

Compare
EU/1/11/743/011-015
Authorised: 22/12/2011
Accord Healthcare S.L.U.
SPC PIL IPAR
REPAGLINIDE KRKA
2 Milligram Tablets

Compare
EU/1/09/579/13-18
Authorised: 04/11/2009
Krka d.d., Novo mesto
SPC PIL IPAR
REPAGLINIDE KRKA
0.5 Milligram Tablets

Compare
EU/1/09/579/1-6
Authorised: 04/11/2009
Krka d.d., Novo mesto
SPC PIL IPAR
REPAGLINIDE KRKA
1 Milligram Tablets

Compare
EU/1/09/579/7-12
Authorised: 04/11/2009
Krka d.d., Novo mesto
SPC PIL IPAR
REPAGLINIDE TEVA
2 Milligram Tablets

Compare
EU/1/09/530/11-15
Authorised: 29/06/2009
Teva B.V.
SPC PIL IPAR
REPAGLINIDE TEVA
0.5 Milligram Tablets

Compare
EU/1/09/530/1-5
Authorised: 29/06/2009
Teva B.V.
SPC PIL IPAR
REPAGLINIDE TEVA
1 Milligram Tablets

Compare
EU/1/09/530/6-10
Authorised: 29/06/2009
Teva Pharma B.V.
SPC PIL IPAR
Repatha
140 milligram(s)/millilitre Solution for injection

Compare
EU/1/15/1016/001-005
Authorised: 17/07/2015
Amgen Europe B.V.
SPC PIL IPAR
Repatha
420 milligram(s) Solution for injection

Compare
EU/1/15/1016/006-007
Authorised: 17/02/2017
Amgen Europe B.V.
SPC PIL IPAR
REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
0.5 millilitre(s) Suspension for injection

Compare
PA2131/006/001
Authorised: 25/07/2003
Sanofi Pasteur
SPC PIL
REPLAGAL 1MG/ML
1mg/ml milligram(s)/millilitre Concentrate for solution for infusion

Compare
EU/1/01/189/001
Authorised: 03/08/2001
Shire Human Genetic Therapies AB
SPC PIL IPAR
REPSO
20 Milligram Film Coated Tablet

Compare
EU/1/11/674/006-010
Authorised: 14/03/2011
Teva B.V.
SPC PIL IPAR
Requip 0.25 mg film-coated tablets
0.25 milligram(s) Film-coated tablet

Compare
PA1077/037/001
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
SPC PIL